Gamida Cell Ltd reports results for the quarter ended in December - Earnings Summary

Gamida Cell

27/03/2024 13:31

* Gamida Cell Ltd  GMDA.OQ  reported a quarterly adjusted
loss
of 4 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -30 cents.  The mean expectation of four analysts for the
quarter was for a loss of 15 cents per share. Wall Street
expected results to range from -19 cents to -13 cents per share.
    * Revenue was $1.11 million​; analysts expected $1.06
million. 
    * Gamida Cell Ltd's reported EPS for the quarter was a loss
of 4
cents​.
    * The company reported a quarterly loss of $8.84 million.
    * Gamida Cell Ltd shares had fallen by 16.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Gamida Cell Ltd
is $5.00 
This summary was machine generated from LSEG data March 27 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.15          -0.04          Beat
 Sep. 30 2023      -0.17          -0.01          Beat
 Jun. 30 2023      -0.19          -0.31          Missed
 Mar. 31 2023      -0.27          -0.27          Met